+12.6%
EBAY vs MRNA
+511.3%
-498.7%
-20.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -2.2% | -0.1% | -2.3% |
| 7D | -2.1% | +5.5% | -7.6% | -2.1% |
| 30D | -6.7% | +158.7% | -165.4% | -8.4% |
| 3M | -5.0% | +182.1% | -187.1% | -7.0% |
| 6M | +14.6% | +151.8% | -137.2% | +11.9% |
| YTD | +19.8% | +393.6% | -373.7% | +21.0% |
| 1Y | +12.6% | +499.5% | -486.9% | +19.7% |
| All | +12.6% | +511.3% | -498.7% | +19.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling